CIC bioGUNE is an internationally competitive research centre dedicated to advancing knowledge in life sciences through a multidisciplinary approach that bridges chemical, molecular and structural biology with immunology and biomedicine. Its scientific strategy integrates cutting-edge omics technologies - including genomics, proteomics, metabolomics, and transcriptomics - to investigate the molecular mechanisms underlying health and disease and to drive the development of innovative diagnostic and therapeutic strategies.

Our scientific activity is organized into two major research programs: Molecular Regulation & Enabling Technologies and Integrative Biomedicine. These programs address major biomedical and societal challenges, including multi-scale data integration, healthy ageing and prevention, precision oncology, and infectious diseases and One Health.

Guided by a collaborative philosophy, CIC bioGUNE fosters dynamic multidisciplinary research initiatives with internal teams and a wide network of national and international collaborators. This includes partnerships with academic institutions, clinical centers, research and technology organizations, and stakeholders across the vibrant biotech and pharmaceutical ecosystem.

Our commitment to scientific excellence is reflected in the award of nine European Research Council (ERC) grants, as well as other prestigious distinctions such as three National Prizes for Science and recognition as a Severo Ochoa Centre of Excellence. The centre is also strongly oriented towards knowledge transfer and innovation through active industrial collaborations and strategic partnerships.

Our research is supported by state-of-the-art infrastructures and technology platforms that position CIC bioGUNE among the top-tier research institutions in Europe. These include advanced facilities for nuclear magnetic resonance, along with core platforms for genomics, proteomics, and metabolomics.

Since its foundation, CIC bioGUNE has acted as a catalyst for scientific advancement, talent attraction, and the development of high-impact technological infrastructures. Over more than two decades, it has evolved into a leading reference institution in Europe, recognised for its multidisciplinary research, advanced omics capabilities, and strong translational focus, contributing both to regional development and to the broader European research landscape.